Mammalian Target of Rapamycin as a Target in Hematological Malignancies

Pharmacology, Toxicology and Pharmaceutical Science

• Mammalian Target of Rapamycin 100%
• Hematologic Malignancy 100%
• Diseases 50%
• Mammalian Target of Rapamycin Inhibitor 50%
• Morbidity 50%
• Pathophysiology 50%
• Mortality 50%
• Drug Discovery 50%

INIS

• malignancies 100%
• data 33%
• drugs 33%
• patients 33%
• mortality 33%
• morbidity 33%